The Role of the Conversion IC Part 2: Verified vs. Unverified Data Sets
In order to be able to truly consult and to make sound recommendations on how to approach certain clinical data elements it is important to know what options exist. One of the main goals heading into a conversion project is to be able to convert as much data as possible in a verified state. Converted items that file into EHR in an already verified state are ideal since they will appear and behave very similar (if not the same) as data that was directly entered into EHR. Unverified items will require that a user and/or provider use the Verify and Add functionality in EHR to promote the item to a verified status. The Verify and Add process guides the user/provider to the appropriate ACI workspace where the unverified item can be queried against the master dictionary, matched up to an appropriate entry, and then committed as a verified item into the record.
Here are some of the essential advantages/disadvantages and potential decision points that might assist in the decision making process with regards to verified vs. unverified data sets.
Impact on workflow and clinical staff – it is important to be aware of the fact that filing items such as Allergens, Problems, and/or Medications as unverified items requires not only additional training and workflow augmentation for the Verify and Add process, but also can take a considerable amount of time and almost make an established patient feel like a new one. Consideration should be given to how the Verify and Add process could potentially fit into the intake process and what (if any) additional resources might be justified in order to Verify and Add items prior to the visit; very similar to chart abstraction.
DUR checking – when considering handling Medications and Medication Allergens as unverified items, it is crucial to understand that DUR checking will NOT take place for unverified items; only for verified items.
Integration with Note – unverified items will NOT fully integrate and auto-cite into a structured note. This is important to know so that there is awareness that items (such as Problems and Meds) need to be verified prior to starting a note if it is desired to have those items auto-cite into the Note. This could adversely impact the amount of time it takes the provider to retrieve information for clinical decision making and also impact on the clinical documentation for the visit.
Charge capture – Problems that are in an unverified state cannot be assessed via the Note or Clinical Desktop. In order for a problem to be assessed in EHR and electronically charged for it must be a in a verified state and associated with a valid ICD9 code.
Display text – when an unverified item is constructed and filed it basically is a string of textual information prior to the Verify and Add process. This is significant because once an item is verified against a native EHR dictionary entry it will take on the display name and attributes of that EHR item. The display name sent over with the unverified item will not persist past Verify and Add so it is important to know what information will remain and which information may need to be keyed in as an additional description or annotation.
The decision to ultimately proceed with verified vs. unverified items can also be driven by external factors related to the legacy system in combination with EHR specific criteria.
Does the source system allow “free text” or “un-coded” items to be added to their clinical record?
Are these items confidently translatable to any of the dictionary items in EHR?
Are the required data dictionary extracts something that the legacy is able and willing to provide in an accurate and timely manner? What is the cooperation level of the legacy vendor?
Consider a situation where the legacy system allows the free text “ad hoc” entry of un-coded Allergens in their clinical record and line items such as “Tylenol/Milk/Blue Dye”. This is a challenge since it is really 3 unique allergens combined into one item. Since this contains both medication and non-medication related allergens it would not be appropriate to build this as its own entry in Allergen dictionary. That being the case there is likely nothing to map an item such as this to in EHR. This situation could then present itself as an appropriate candidate for unverified items. That way at the point of review and intake (or during chart abstraction) this item can be reviewed, confirmed, and then split out into 3 unique EHR entries that will properly partake in DUR checking and be safer for the patient.







